Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Cystic fibrosis–related diabetes is caused by islet loss and inflammation
Nathaniel J. Hart, … , Patrick E. MacDonald, Alvin C. Powers
Nathaniel J. Hart, … , Patrick E. MacDonald, Alvin C. Powers
Published April 19, 2018
Citation Information: JCI Insight. 2018;3(8):e98240. https://doi.org/10.1172/jci.insight.98240.
View: Text | PDF
Research Article Cell biology Endocrinology

Cystic fibrosis–related diabetes is caused by islet loss and inflammation

  • Text
  • PDF
Abstract

Cystic fibrosis–related (CF-related) diabetes (CFRD) is an increasingly common and devastating comorbidity of CF, affecting approximately 35% of adults with CF. However, the underlying causes of CFRD are unclear. Here, we examined cystic fibrosis transmembrane conductance regulator (CFTR) islet expression and whether the CFTR participates in islet endocrine cell function using murine models of β cell CFTR deletion and normal and CF human pancreas and islets. Specific deletion of CFTR from murine β cells did not affect β cell function. In human islets, CFTR mRNA was minimally expressed, and CFTR protein and electrical activity were not detected. Isolated CF/CFRD islets demonstrated appropriate insulin and glucagon secretion, with few changes in key islet-regulatory transcripts. Furthermore, approximately 65% of β cell area was lost in CF donors, compounded by pancreatic remodeling and immune infiltration of the islet. These results indicate that CFRD is caused by β cell loss and intraislet inflammation in the setting of a complex pleiotropic disease and not by intrinsic islet dysfunction from CFTR mutation.

Authors

Nathaniel J. Hart, Radhika Aramandla, Gregory Poffenberger, Cody Fayolle, Ariel H. Thames, Austin Bautista, Aliya F. Spigelman, Jenny Aurielle B. Babon, Megan E. DeNicola, Prasanna K. Dadi, William S. Bush, Appakalai N. Balamurugan, Marcela Brissova, Chunhua Dai, Nripesh Prasad, Rita Bottino, David A. Jacobson, Mitchell L. Drumm, Sally C. Kent, Patrick E. MacDonald, Alvin C. Powers

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2011 Total
Citations: 5 8 13 19 19 13 12 4 1 94
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (94)

Title and authors Publication Year
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C, Zhao Y
Signal Transduction and Targeted Therapy 2025
Identification of a vimentin-expressing α-cell phenotype in CF and normal pancreas
Kattner N, Hang Y, Krentz NA, Russell LA, Palmer M, Flaxman C, Plett N, Coulthard R, Al-Selwi Y, Dyson N, Honkanen-Scott M, Kim SK, Tiniakos D, Klöppel G, Richardson SJ, Shaw JA
The Journal of Endocrinology 2025
Elevated glucose increases methicillin-resistant Staphylococcus aureus antibiotic tolerance in a cystic fibrosis airway epithelial cell infection model
Hughes EM, Hirsch MJ, Huffines JT, Krick S, Kiedrowski MR
Research Square 2025
Sex disparities in cystic fibrosis in the era of highly effective modulator treatment.
McNally E, Casey M
BMC pulmonary medicine 2025
Effects of Elevated Glucose on Bacterial Respiratory Infections in Cystic Fibrosis and Chronic Airway Diseases
Hughes EM, Kiedrowski MR
International Journal of Molecular Sciences 2025
Islet protein expression of GLP-1 receptor, but not GLP-1, is reduced in cystic fibrosis-related diabetes
Sina Gharib, Rachna Vemireddy, Joseph Castillo, Brendy Fountaine, Theo Bammler, James MacDonald, Rebecca Hull, Sakeneh Zraika
Scientific reports 2024
Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis
Anton-Păduraru DT, Murgu AM, Bozomitu LI, Mîndru DE, Iliescu Halițchi CO, Trofin F, Ciongradi CI, Sârbu I, Eṣanu IM, Azoicăi AN
Diagnostics 2024
The Changing Landscape of Treatment for Cystic Fibrosis Related Diabetes
Amini M, Yu K, Liebich J, Ahir V, Wood E, Albert S, Dhindsa S
Journal of Clinical & Translational Endocrinology 2024
Metabolic Syndrome and Tendon Disease: A Comprehensive Review
Lai C, Li R, Tang W, Liu J, Duan XD, Bao D, Liu H, Fu S
2024
Development of the Pancreatic Ducts and Their Contribution to Organogenesis.
Dale DJ, Rutan CD, Mastracci TL
Advances in anatomy, embryology, and cell biology 2024
Changes in immunofluorescence staining during islet regeneration in a cystic fibrosis-related diabetes (CFRD) ferret model
Mohammed SM, Bone RN, Aquino JD, Mirmira RG, Evans-Molina C, Ismail HM
Islets 2024
Heterogeneous endocrine cell composition defines human islet functional phenotypes
Evans-Molina C, Pettway YD, Saunders DC, Sharp SA, Bate TS, Sun H, Durai H, Mei S, Coldren A, Davis C, Reihsmann CV, Hopkirk AL, Taylor J, Bradley A, Aramandla R, Poffenberger G, Eskaros A, Jenkins R, Shi D, Kang H, Rajesh V, Thaman S, Feng F, Cartailler JP, Powers AC, Abraham K, Gloyn AL, Niland JC, Brissova M
bioRxiv 2024
CFTR represses a PDX1 axis to govern pancreatic ductal cell fate
Rotti PG, Yi Y, Gasser G, Yuan F, Sun X, Apak-Evans I, Wu P, Liu G, Choi S, Reeves R, Scioneaux AE, Zhang Y, Winter M, Liang B, Cunicelli N, Uc A, Norris AW, Sussel L, Wells KL, Engelhardt JF
iScience 2024
Pancreatic regional blood flow links the endocrine and exocrine diseases
Adam Rizk, Michael Dybala, Khalil Rodriguez, Manami Hara
Journal of Clinical Investigation 2023
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings
Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Pandol SJ, Sander M
Diabetes 2023
Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation
Fonseca Ó, Gomes MS, Amorim MA, Gomes AC
Biomolecules 2023
Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
Putman MS, Norris AW, Hull RL, Rickels MR, Sussel L, Blackman SM, Chan CL, Ode KL, Daley T, Stecenko AA, Moran A, Helmick MJ, Cray S, Alvarez JA, Stallings VA, Tuggle KL, Clancy JP, Eggerman TL, Engelhardt JF, Kelly A
Diabetes 2023
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS, Norris AW, Hull RL, Rickels MR, Sussel L, Blackman SM, Chan CL, Ode KL, Daley T, Stecenko AA, Moran A, Helmick MJ, Cray S, Alvarez JA, Stallings VA, Tuggle KL, Clancy JP, Eggerman TL, Engelhardt JF, Kelly A
Diabetes care 2023
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes
Lurquin F, Gohy S, Hermans MP, Preumont V
Journal of Clinical & Translational Endocrinology 2023
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes
Kattner N
Therapeutic Advances in Endocrinology and Metabolism 2023
Islet cells in human type 1 diabetes: from recent advances to novel therapies - a symposium-based roadmap for future research.
Cantley J, Eizirik DL, Latres E, Dayan CM
The Journal of endocrinology 2023
Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
Pinzaru AD, Mihai CM, Chisnoiu T, Pantazi AC, Lupu VV, Kassim MA, Lupu A, Grosan E, Al Jumaili AZ, Ion I, Stoleriu G, Ion I
Biomedicines 2023
Genetic risk converges on regulatory networks mediating early type 2 diabetes.
Walker JT, Saunders DC, Rai V, Chen HH, Orchard P, Dai C, Pettway YD, Hopkirk AL, Reihsmann CV, Tao Y, Fan S, Shrestha S, Varshney A, Petty LE, Wright JJ, Ventresca C, Agarwala S, Aramandla R, Poffenberger G, Jenkins R, Mei S, Hart NJ, Phillips S, Kang H, Greiner DL, Shultz LD, Bottino R, Liu J, Below JE, Parker SCJ, Powers AC, Brissova M
Nature 2023
Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes
Malik SS, Padmanabhan D, Hull-Meichle RL
Frontiers in Endocrinology 2023
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents
Anton-Păduraru DT, Murgu AM, Donos MA, Trofin F, Azoicăi AN, Popovici P, Stana AB, Gheorghiescu I, Trandafir LM
Children 2023
Exocrine Pancreas in Type 1 and Type 2 Diabetes: Different Patterns of Fibrosis, Metaplasia, Angiopathy, and Adiposity
Wright JJ, Eskaros A, Windon A, Bottino R, Jenkins R, Bradley AM, Aramandla R, Philips S, Kang H, Saunders DC, Brissova M, Powers AC
Diabetes 2023
Effects of GLP-1 and GIP on islet function in glucose intolerant, pancreatic insufficient cystic fibrosis
Sarah Nyirjesy, Amy Peleckis, Jack Eiel, Kathryn Gallagher, Andriana Doliba, Abigail Tami, Anneliese J. Flatt, Diva Leon, Denis Hadjiliadis, Saba Sheikh, Darko Stefanovski, Robert Gallop, David D'Alessio, Ronald Rubenstein, Andrea Kelly, Michael R. Rickels
Diabetes 2022
The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes
S Hasan, S Soltman, C Wood, SM Blackman
Journal of Clinical & Translational Endocrinology 2022
Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
I Korten, E Kieninger, L Krueger, M Bullo, C Flück, P Latzin, C Casaulta, C Boettcher
Frontiers in Pediatrics 2022
Angiotensin(1–7) activates MAS-1 and upregulates CFTR to promote insulin secretion in pancreatic β-cells: the association with type 2 diabetes
X Zhang, X Zhao, Y Wu, W Huang, J Chen, P Hu, W Liu, Y Chen, J Hao, R Xie, H Chan, Y Ruan, H Chen, J Guo
Endocrine Connections 2022
A Hyperglycemic Microenvironment Inhibits Tendon-to-Bone Healing through the let-7b-5p/CFTR Pathway
T Cao, J Hong, F Qi, B Zheng, G Chen, B Yu, F Ye, M Tang
Computational and mathematical methods in medicine 2022
The role of modulators in cystic fibrosis related diabetes
L Merjaneh, S Hasan, N Kasim, K Ode
Journal of Clinical & Translational Endocrinology 2022
The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
Hasan S, Khan MS, Lansang MC
Journal of Clinical & Translational Endocrinology 2022
Enteroendocrine Cell Formation Is an Early Event in Pancreatic Tumorigenesis
Caplan LR, Vavinskaya V, Gelikman DG, Jyotsana N, Trinh VQ, Olive KP, Tan MC, DelGiorno KE
Frontiers in physiology 2022
The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism—A Review with Currently Available Evidence
Ciochina M, Balaban DV, Manucu G, Jinga M, Gheorghe C
Biomolecules 2022
Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis
Ferrari V, Terlizzi V, Stagi S
Journal of Clinical Medicine 2022
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis
Piona C, Mozzillo E, Tosco A, Volpi S, Rosanio FM, Cimbalo C, Franzese A, Raia V, Zusi C, Emiliani F, Boselli ML, Trombetta M, Bonadonna RC, Cipolli M, Maffeis C
Journal of Clinical Medicine 2022
Oxidative stress and impaired insulin secretion in cystic fibrosis pig pancreas
O\u2019Malley Y, Coleman MC, Sun X, Lei J, Yao J, Pulliam CF, Kluz P, McCormick ML, Yi Y, Imai Y, Engelhardt JF, Norris AW, Spitz DR, Uc A
2022
Exocrine-Endocrine Crosstalk: The Influence of Pancreatic Cellular Communications on Organ Growth, Function and Disease
Overton DL, Mastracci TL
Frontiers in Endocrinology 2022
CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy
Crow H, Bengtson C, Shi X, Graves L III, Anabtawi A
Journal of Clinical & Translational Endocrinology 2022
An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
Montemari AL, Manco M, Fiocchi AG, Bartoli M, Facchiano F, Tabolacci C, Scatigna M, Ciciriello F, Alghisi F, Montemitro E, Carsetti R, Lucidi V, Fiscarelli EV
Journal of inflammation research 2022
Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis
Chan CL, Granados A, Moheet A, Singh S, Vigers T, Arbeláez AM, Yi Y, Hu S, Norris AW, Ode KL
Journal of Clinical & Translational Endocrinology 2022
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
Ode KL, Ballman M, Battezzati A, Brennan A, Chan CL, Hameed S, Ismail HM, Kelly A, Moran AM, Rabasa\u2010Lhoret R, Saxby NA, Craig ME
Pediatric Diabetes 2022
Endocrine Complications of Cystic Fibrosis
Kelly A, Marks BE, Stalvey MS
Clinics in Chest Medicine 2022
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.
Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Sander M, Pandol SJ
Pancreas 2022
β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies
A Al-Mrabeh
Biomedicines 2021
The Human Islet: Mini-Organ With Mega-Impact
JT Walker, DC Saunders, M Brissova, AC Powers
Endocrine reviews 2021
Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies
E Gál, J Dolenšek, A Stožer, L Czakó, A Ébert, V Venglovecz
Frontiers in Endocrinology 2021
Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes
Y Al-Selwi, JA Shaw, N Kattner
Clinical Medicine Insights. Endocrinology and Diabetes 2021
Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
F Iafusco, G Maione, FM Rosanio, E Mozzillo, A Franzese, N Tinto
Diagnostics 2021
The Potential Causes of Cystic Fibrosis-Related Diabetes
L Coderre, L Debieche, J Plourde, R Rabasa-Lhoret, S Lesage
Frontiers in Endocrinology 2021
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
A Moheet, D Beisang, L Zhang, SD Sagel, JM VanDalfsen, SL Heltshe, C Frederick, M Mann, N Antos, J Billings, SM Rowe, A Moran
Journal of Cystic Fibrosis 2021
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
H Gaines, KR Jones, J Lim, NF Medhi, S Chen, RH Scofield
Journal of Diabetes and its Complications 2021
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
S Kahn, Y Chen, N Esser, A Taylor, D van Raalte, S Zraika, C Verchere
Endocrine reviews 2021
Cystic fibrosis-related diabetes and lung disease: an update
BJ Prentice, A Jaffe, S Hameed, CF Verge, S Waters, J Widger
European Respiratory Review 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
DP Nichols, SH Donaldson, CA Frederick, SD Freedman, D Gelfond, LR Hoffman, A Kelly, MR Narkewicz, JE Pittman, F Ratjen, SD Sagel, M Rosenfeld, SJ Schwarzenberg, PK Singh, GM Solomon, MS Stalvey, S Kirby, JM VanDalfsen, JP Clancy, SM Rowe
Journal of Cystic Fibrosis 2021
Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus
E Westholm, A Wendt, L Eliasson
Clinical Medicine Insights. Endocrinology and Diabetes 2021
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
W Cefalu, D Andersen, G Arreaza-Rubín, C Pin, S Sato, C Verchere, M Woo, N Rosenblum
Diabetes care 2021
Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes
A Toner, A McCloy, P Dyce, D Nazareth, F Frost
Cochrane Database of Systematic Reviews 2021
The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis
C Chan, L Pyle, T Vigers, P Zeitler, K Nadeau
The Journal of clinical endocrinology and metabolism 2021
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
K Scully, P Marchetti, G Sawicki, A Uluer, M Cernadas, R Cagnina, J Kennedy, M Putman
Journal of Cystic Fibrosis 2021
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND
Diabetes 2021
Interpreting type 1 diabetes risk with genetics and single cell epigenomics
Chiou J, Geusz RJ, Okino ML, Han JY, Miller M, Melton R, Beebe E, Benaglio P, Huang S, Korgaonkar K, Heller S, Kleger A, Preissl S, Gorkin DU, Sander M, Gaulton KJ
Nature 2021
A Prospective Study of the Effects of Sex Hormones on Lung Function and Inflammation in Women with Cystic Fibrosis
Holtrop M, Heltshe S, Shabanova V, Keller A, Schumacher L, Fernandez L, Jain R
Annals of the American Thoracic Society 2021
Integrated human pseudoislet system and microfluidic platform demonstrates differences in G-protein-coupled-receptor signaling in islet cells
John T. Walker, Rachana Haliyur, Heather A. Nelson, Matthew Ishahak, Gregory Poffenberger, Radhika Aramandla, Conrad Reihsmann, Joseph R. Luchsinger, Diane C. Saunders, Peng Wang, Adolfo Garcia-Ocana, Rita Bottino, Ashutosh Agarwal, Alvin C. Powers, Marcela Brissova
JCI Insight 2020
Heterogeneous expression of CFTR in insulin-secreting β-cells of the normal human islet
MD Fulvio, M Bogdani, M Velasco, TS McMillen, C Ridaura, L Kelly, MM Almutairi, S Kursan, AA Sajib, M Hiriart, L Aguilar-Bryan, B Blondeau
PloS one 2020
Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
A Al-Mrabeh
Cardiovascular endocrinology & metabolism 2020
Implications of Integrated Pancreatic Microcirculation: Crosstalk between Endocrine and Exocrine Compartments
MP Dybala, LR Gebien, ME Reyna, Y Yu, M Hara
Diabetes 2020
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia
MJ Kilberg, S Sheikh, D Stefanovski, C Kubrak, DD Leon, D Hadjiliadis, RC Rubenstein, MR Rickels, A Kelly
Journal of Cystic Fibrosis 2020
In silico prediction and validation of potential therapeutic genes in pancreatic β‑cells associated with type 2 diabetes
D Zhou, X Mou, K Liu, W Liu, Y Xu, D Zhou
Experimental and therapeutic medicine 2020
A tale of two pancreases: exocrine pathology and endocrine dysfunction
MR Rickels, AW Norris, RL Hull
Diabetologia 2020
Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
F Brinkmann, B Hanusch, M Ballmann, S Mayorandan, A Bollenbach, K Chobanyan-Jürgens, K Jansen, A Schmidt-Choudhury, N Derichs, D Tsikas, T Lücke
Journal of Clinical Medicine 2020
Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis
F Pineau, D Caimmi, M Magalhães, E Fremy, A Mohamed, L Mely, S Leroy, M Murris, M Claustres, R Chiron, AD Sario, B Bardoni
PloS one 2020
Cystic fibrosis-related diabetes: The unmet need
L Pozo, F Bello, Y Mendez, S Surani
World journal of diabetes 2020
Revealing the Interactions Between Diabetes, Diabetes-Related Diseases, and Cancers Based on the Network Connectivity of Their Related Genes
L Zhu, J Xiang, Q Wang, A Wang, C Li, G Tian, H Zhang, S Chen
Frontiers in Genetics 2020
Pancreatlas: Applying an Adaptable Framework to Map the Human Pancreas in Health and Disease
D Saunders, J Messmer, I Kusmartseva, M Beery, M Yang, M Atkinson, A Powers, J Cartailler, M Brissova
2020
Overview of Atypical Diabetes
J Tamaroff, M Kilberg, S Pinney, S McCormack
Endocrinology and metabolism clinics of North America 2020
The supply chain of human pancreatic beta cell lines
Raphaël Scharfmann, Willem Staels, Olivier Albagli-Curiel
Journal of Clinical Investigation 2019
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis
Anh-Thu N. Lam, Melis A Aksit, Briana Vecchio-Pagan, Celeste A Shelton, Derek L. Osorio, Arianna F Anzmann, Loyal A Goff, David C. Whitcomb, Scott M Blackman, Garry Cutting
Journal of Clinical Investigation 2019
Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy
A Kelly, DD Leon, S Sheikh, D Camburn, C Kubrak, AJ Peleckis, D Stefanovski, D Hadjiliadis, MR Rickels, RC Rubenstein
American journal of respiratory and critical care medicine 2019
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
D Khan, R Kelsey, RR Maheshwari, VM Stone, A Hasib, FN Koivula, A Watson, S Harkin, N Irwin, JA Shaw, NH McClenaghan, V Venglovecz, A Ébert, M Flodström-Tullberg, MG White, C Kelly
Scientific Reports 2019
In Situ Analysis Reveals That CFTR Is Expressed in Only a Small Minority of β-Cells in Normal Adult Human Pancreas
MG White, RR Maheshwari, SJ Anderson, R Berlinguer-Palmini, C Jones, SJ Richardson, PG Rotti, SL Armour, Y Ding, N Krasnogor, JF Engelhardt, MA Gray, NG Morgan, JA Shaw
The Journal of clinical endocrinology and metabolism 2019
Survival in a bad neighborhood: pancreatic islets in cystic fibrosis
AW Norris, KL Ode, L Merjaneh, S Sanda, Y Yi, X Sun, JF Engelhardt, RL Hull
Journal of Endocrinology 2019
Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
R Kelsey, FN Koivula, NH McClenaghan, C Kelly
Clinical Medicine Insights. Endocrinology and Diabetes 2019
Chloride transporters and channels in β-cell physiology: revisiting a 40-year-old model
MD Fulvio, L Aguilar-Bryan
Biochemical Society Transactions 2019
Is Cystic Fibrosis–related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion
AW Norris
American journal of respiratory and critical care medicine 2019
Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis–Related Diabetes
F Christian, A Thierman, E Shirley, K Allen, C Cross, K Jones
Journal of Investigative Medicine High Impact Case Reports 2019
Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue
BM Prentice, NJ Hart, N Phillips, R Haliyur, A Judd, R Armandala, JM Spraggins, CL Lowe, KL Boyd, RW Stein, CV Wright, JL Norris, AC Powers, M Brissova, RM Caprioli
Diabetologia 2019
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
J Colomba, SR Netedu, C Lehoux-Dubois, A Coriati, V Boudreau, F Tremblay, K Cusi, R Rabasa-Lhoret, JA Leey, W Ding
PloS one 2019
Human islets expressing HNF1A variant have defective β-cell transcriptional regulatory networks
Rachana Haliyur, Xin Tong, May Sanyoura, Shristi Shrestha, Jill Lindner, Diane Saunders, Radhika Aramandla, Gregory Poffenberger, Sambra D. Redick, Rita Bottino, Nripesh Prasad, Shawn E Levy, Raymond D Blind, David M Harlan, Louis Philipson, Roland Stein, Marcela Brissova, Alvin C Powers
Journal of Clinical Investigation 2018
Recent advances in developing therapeutics for cystic fibrosis
LJ Strug, AL Stephenson, N Panjwani, A Harris
Human Molecular Genetics 2018
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
NJ Hart, AC Powers
Diabetologia 2018
An Increase in Chromogranin A-Positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis
M Cory, A SalehMoin, A Moran, RA Rizza, PC Butler, S Dhawan, AE Butler
Journal of the Endocrine Society 2018
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts